ReShape Lifesciences Stock Rocketed 61% Today – Here’s Why

Shares of ReShape Lifesciences Inc. (RSLS) jumped 61% on Wednesday after Vyome Therapeutics, Inc. announced that the Nasdaq Stock Market approved its listing upon completion of its merger with ReShape.

The merger is expected to take effect for marketplace purposes with the opening of trading on Friday, Aug. 15, 2025, under the name Vyome Holdings, Inc. and the trading symbol “HIND.”

“Nasdaq’s approval is right on track and now we are marching forward to ring the bell on our planned listing date this Friday,” Vyome Chairman Krishna Gupta said.

On Stocktwits, retail sentiment around ReShape LifeSciences jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours while message volume rose from ‘low’ to ‘high’ levels.

ReShape Lifesciences Inc. entered into a definitive merger agreement with India’s Vyome Therapeutics, Inc. in July 2024, under which ReShape and Vyome will combine in an all-stock transaction. While Vyome is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases, ReShape Lifesciences is a weight loss and metabolic health solutions company.

The combined company, of which existing ReShape stockholders will own approximately 11.1%, will focus on advancing the development of immuno-inflammatory assets, the companies had said.

Vyome on Wednesday also stated that the ReShape board of directors has declared a 1-for-4 reverse stock split of the company’s common stock, which will also be effective for marketplace purposes upon the commencement of trading on August 15, 2025. The reverse split does not impact the post-merger ownership allocations between the ReShape and Vyome shareholders in the deal, it noted.

ReShape shareholders approved all of the proposals necessary to complete the merger earlier this month.

RSLS stock is down by 97% this year and by about 99% over the past 12 months.

Read also: Goldman Sachs Economist Sticks To Tariff Warning After Trump’s Criticism

For updates and corrections, email newsroom[at]stocktwits[dot]com.